WHO Prequalifies First Ever Biosimilar
Paves Way For Ontruzant's Accelerated Registration In 41 Countries
Executive Summary
Samsung Bioepis’ Ontruzant trastuzumab biosimilar has become the first biosimilar to be prequalified by the World Health Organization.